A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemia

Epigenetics

Volumn 7, Issue 6, 2012, Pages 535-541

  Wong, Nicholas C ^a   Ashley, David ^b   Chatterton, Zac ^a   Parkinson Bates, Mandy ^c   Ng, Hong Kiat ^c   Halemba, Minhee S ^c   Kowalczyk, Adam ^a   Bedo, Justin ^a   Wang, Qiao ^a   Bell, Katrina ^c   Algar, Elizabeth ^a,c   Craig, Jeffrey M ^a   Saffery, Richard ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

Childhood acute lymphoblastic leukemia; DNA methylation; Pre B cell acute lymphoblastic leukemia

Indexed keywords

CD34 ANTIGEN; DNA; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW BIOPSY; CANCER DIAGNOSIS; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; DISEASE FREE INTERVAL; DNA METHYLATION; ETV6 GENE; FEMALE; GENE; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA REMISSION; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRE B CELL ACUTE LYMPHOBLASTIC LEUKEMIA; PRE B LYMPHOCYTE; PRESCHOOL CHILD; RUNX1 GENE; SCHOOL CHILD;

EID: 84861939584     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.20193     Document Type: Article

References (23)

1. Pui CH, Carroll WL, Meshinchi S, Arceci RJ. Biology, risk stratification and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011; 29:551-565; PMID:21220611; http://dx.doi.org/10.1200/JCO.2010.30.7405.
2. Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 1997; 94:13950-13954; PMID:9391133; http://dx.doi.org/10.1073/pnas.94.25.13950.
3. Bernardin F, Yang Y, Cleaves R, Zahurak M, Cheng L, Civin CI, et al. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. Cancer Res 2002; 62:3904-8; PMID:12124316.
4. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446:758-764; PMID:17344859; http://dx.doi.org/10.1038/nature05690.
5. Gutiérrez MI, Siraj AK, Ibrahim MM, Hussain A, Bhatia K. Childhood and adult ALL: differences in epigenetic lesions associated with cell cycle genes. Am J Hematol 2005; 80:158-160; PMID:16184585; http://dx.doi.org/10.1002/ajh.20458.
6. Chatterton Z, Morenos L, Saffery R, Craig JM, Ashley D, Wong NC. DNA methylation and miRNA expression profiling in childhood B-cell acute ymphoblastic leukemia. Epigenomics 2010; 2:697-708; PMID:22122053; http://dx.doi.org/10.2217/epi.10.39.
7. Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4:44-57; PMID:19131956; http://dx.doi.org/10.1038/nprot.2008.211.
8. Martin-Subero JI, Ammerpohl O, Bibikova M, Wickham-Garcia E, Agirre X, Alvarez S, et al. A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS One 2009; 4:6986; PMID:19750229; http://dx.doi.org/10.1371/journal.pone.0006986.
9. Ogino S, Shima K, Baba Y, Nosho K, Irahara N, Kure S, et al. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis. Gastroenterology 2009; 136:1242-1250; PMID:19186181; http://dx.doi.org/10.1053/j.gastro.2008.12.048.
10. Sun J, Chen Z, Zhu T, Yu J, Ma K, Zhang H, et al. Hypermethylated SFRP1, but none of other nine genes "informative" for western countries, is valuable for bladder cancer detection in Mainland China. J Cancer Res Clin Oncol 2009; 135:1717-1727; PMID:19565266; http://dx.doi.org/10.1007/s00432-009-0619-z.
11. Katoh M, Katoh M. Human FOX gene family (Review). Int J Oncol 2004; 25:1495-500; PMID:15492844.
12. Lin YC, Jhunjhunwala S, Benner C, Heinz S, Welinder E, Mansson R, et al. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol 2010; 11:635-43; PMID:20543837; http://dx.doi.org/10.1038/ni.1891.
13. Scholz C, Nimmrich I, Burger M, Becker E, Dörken B, Ludwig WD, et al. Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis. Ann Hematol 2005; 84:236-44; PMID:15538567; http://dx.doi.org/10.1007/s00277-004-0969-1.
14. Ballerini P, Landman-Parker J, Cayuela JM, Asnafi V, Labopin M, Gandemer V, et al. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome. Haematologica 2008; 93:1658-65; PMID:18835836; http://dx.doi.org/10.3324/haematol.13291.
15. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, et al. Classification, subtype discovery and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1:133-43; PMID:12086872; http://dx.doi.org/10.1016/S1535-6108(02)00032-6.
16. van Zelm MC, van der Burg M, de Ridder D, Barendregt BH, de Haas EF, Reinders MJ, et al. Ig gene rearrangement steps are initiated in early human precursor B cell subsets and correlate with specific transcription factor expression. J Immunol 2005; 175:5912-22; PMID:16237084.
17. Auer RL, Starczynski J, McElwaine S, Bertoni F, Newland AC, Fegan CD, et al. Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia. Genes Chromosomes Cancer 2005; 43:1-10; PMID:15672409; http://dx.doi.org/10.1002/gcc.20159.
18. Toman I, Loree J, Klimowicz AC, Bahlis N, Lai R, Belch A, et al. Expression and prognostic significance of Oct2 and Bob1 in multiple myeloma: implications for targeted therapeutics. Leuk Lymphoma 2011; 52:659-67; PMID:21438833; http://dx.doi.org/10.3109/10428194.2010.548535.
19. Advani AS, Lim K, Gibson S, Shadman M, Jin T, Copelan E, et al. OCT-2 expression and OCT-2/BOB.1 co-expression predict prognosis in patients with newly diagnosed acute myeloid leukemia. Leuk Lymphoma 2010; 51:606-612; PMID:20141429; http://dx.doi.org/10.3109/10428191003592735.
20. Cazzaniga G, Valsecchi MG, Gaipa G, Conter V, Biondi A. Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia. Br J Haematol 2011; 155:45-52; PMID:21812769; http://dx.doi.org/10.1111/j.1365-2141.2011.08795.x.
21. Fackler MJ, Umbricht CB, Williams D, Argani P, Cruz LA, Merino VF, et al. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res 2011; 71:6195-207; PMID:21825015; http://dx.doi.org/10.1158/0008-5472.CAN-11-1630.
22. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 2012; 22:271-82; PMID:21659424; http://dx.doi.org/10.1101/gr.117523.110.
23. Fang F, Turcan S, Rimner A, Kaufman A, Giri D, Morris LG, et al. Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci Transl Med 2011; 3:75; PMID:21430268; http://dx.doi.org/10.1126/scitranslmed.3001875.